169 related articles for article (PubMed ID: 29869268)
21. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
Cai R; Chen C
Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
[TBL] [Abstract][Full Text] [Related]
22. Layer-by-layer assembly of viral nanoparticles and polyelectrolytes: the film architecture is different for spheres versus rods.
Steinmetz NF; Findlay KC; Noel TR; Parker R; Lomonossoff GP; Evans DJ
Chembiochem; 2008 Jul; 9(10):1662-70. PubMed ID: 18536062
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional plant virus nanoparticles: An emerging strategy for therapy of cancer.
Azizi M; Shahgolzari M; Fathi-Karkan S; Ghasemi M; Samadian H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(6):e1872. PubMed ID: 36450366
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution of Filamentous Plant Virus Nanoparticles: Pepino Mosaic Virus versus Potato Virus X.
Le DHT; Méndez-López E; Wang C; Commandeur U; Aranda MA; Steinmetz NF
Biomacromolecules; 2019 Jan; 20(1):469-477. PubMed ID: 30516960
[TBL] [Abstract][Full Text] [Related]
25. The nano-plasma interface: Implications of the protein corona.
Wolfram J; Yang Y; Shen J; Moten A; Chen C; Shen H; Ferrari M; Zhao Y
Colloids Surf B Biointerfaces; 2014 Dec; 124():17-24. PubMed ID: 24656615
[TBL] [Abstract][Full Text] [Related]
26. Next-generation viral nanoparticles for targeted delivery of therapeutics: Fundamentals, methods, biomedical applications, and challenges.
Tan JS; Jaffar Ali MNB; Gan BK; Tan WS
Expert Opin Drug Deliv; 2023; 20(7):955-978. PubMed ID: 37339432
[TBL] [Abstract][Full Text] [Related]
27. Nonionic block copolymers assemble on the surface of protein bionanoparticle.
Liu Z; Gu J; Wu M; Jiang S; Wu D; Wang Q; Niu Z; Huang Y
Langmuir; 2012 Aug; 28(33):11957-61. PubMed ID: 22877605
[TBL] [Abstract][Full Text] [Related]
28. Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles.
Park J; Chariou PL; Steinmetz NF
Bioconjug Chem; 2020 May; 31(5):1408-1416. PubMed ID: 32281790
[TBL] [Abstract][Full Text] [Related]
29. No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.
Docter D; Strieth S; Westmeier D; Hayden O; Gao M; Knauer SK; Stauber RH
Nanomedicine (Lond); 2015 Feb; 10(3):503-19. PubMed ID: 25707981
[TBL] [Abstract][Full Text] [Related]
30. Interaction of spin-labeled HPMA-based nanoparticles with human blood plasma proteins - the introduction of protein-corona-free polymer nanomedicine.
Klepac D; Kostková H; Petrova S; Chytil P; Etrych T; Kereïche S; Raška I; Weitz DA; Filippov SK
Nanoscale; 2018 Mar; 10(13):6194-6204. PubMed ID: 29560983
[TBL] [Abstract][Full Text] [Related]
31. Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers.
Shukla S; Myers JT; Woods SE; Gong X; Czapar AE; Commandeur U; Huang AY; Levine AD; Steinmetz NF
Biomaterials; 2017 Mar; 121():15-27. PubMed ID: 28063980
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
Bruckman MA; Randolph LN; VanMeter A; Hern S; Shoffstall AJ; Taurog RE; Steinmetz NF
Virology; 2014 Jan; 449():163-73. PubMed ID: 24418549
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
34. Nanomaterials: impact on cells and cell organelles.
Krpetić Z; Anguissola S; Garry D; Kelly PM; Dawson KA
Adv Exp Med Biol; 2014; 811():135-56. PubMed ID: 24683031
[TBL] [Abstract][Full Text] [Related]
35. Cargo-Compatible Encapsulation in Virus-Based Nanoparticles.
Li L; Xu C; Zhang W; Secundo F; Li C; Zhang ZP; Zhang XE; Li F
Nano Lett; 2019 Apr; 19(4):2700-2706. PubMed ID: 30895793
[TBL] [Abstract][Full Text] [Related]
36. Template-Directed Synthesis of Porous and Protective Core-Shell Bionanoparticles.
Li S; Dharmarwardana M; Welch RP; Ren Y; Thompson CM; Smaldone RA; Gassensmith JJ
Angew Chem Int Ed Engl; 2016 Aug; 55(36):10691-6. PubMed ID: 27485579
[TBL] [Abstract][Full Text] [Related]
37. Engineering of Brome mosaic virus for biomedical applications.
Yildiz I; Tsvetkova I; Wen AM; Shukla S; Masarapu MH; Dragnea B; Steinmetz NF
RSC Adv; 2012 May; 2(9):3670-3677. PubMed ID: 28018580
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
39. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
40. Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier.
Zhao X; Chen L; Luckanagul JA; Zhang X; Lin Y; Wang Q
Chembiochem; 2015 Jun; 16(9):1279-83. PubMed ID: 25914312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
